{"id":"https://openalex.org/W7223173276","doi":"https://doi.org/10.17925/ee.2026.22.2.3","title":"Type 2 diabetes and the cardio\u2013renal\u2013metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists","display_name":"Type 2 diabetes and the cardio\u2013renal\u2013metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223173276","doi":"https://doi.org/10.17925/ee.2026.22.2.3","pmid":"https://pubmed.ncbi.nlm.nih.gov/42979257","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13730168"},"language":"en","primary_location":{"id":"doi:10.17925/ee.2026.22.2.3","doi":"https://doi.org/10.17925/ee.2026.22.2.3","is_oa":true,"landing_page_url":"https://doi.org/10.17925/ee.2026.22.2.3","pdf_url":"https://touchendocrinology.com/wp-content/uploads/sites/5/2026/08/4.-touchENDO_22.2_Young_10-19.pdf","source":{"id":"https://openalex.org/S2764519077","display_name":"touchREVIEWS in Endocrinology","issn_l":"1758-3772","issn":["1758-3772","1758-3780","2752-5457"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"touchREVIEWS in Endocrinology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://touchendocrinology.com/wp-content/uploads/sites/5/2026/08/4.-touchENDO_22.2_Young_10-19.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159226441","display_name":"Clipper F Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24624658","display_name":"Touro University California","ror":"https://ror.org/0556gk990","country_code":"US","type":"education","lineage":["https://openalex.org/I24624658"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Clipper F Young","raw_affiliation_strings":["Touro University California College of Osteopathic Medicine, Vallejo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Touro University California College of Osteopathic Medicine, Vallejo, CA, USA","institution_ids":["https://openalex.org/I24624658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023516","display_name":"Namrita George","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133999245","display_name":"University of Nevada, Las Vegas","ror":"https://ror.org/0406gha72","country_code":"US","type":"education","lineage":["https://openalex.org/I133999245"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Namrita George","raw_affiliation_strings":["Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, NV, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, NV, USA","institution_ids":["https://openalex.org/I133999245"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159236267","display_name":"Alexander Olson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24624658","display_name":"Touro University California","ror":"https://ror.org/0556gk990","country_code":"US","type":"education","lineage":["https://openalex.org/I24624658"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Olson","raw_affiliation_strings":["Touro University California College of Osteopathic Medicine, Vallejo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Touro University California College of Osteopathic Medicine, Vallejo, CA, USA","institution_ids":["https://openalex.org/I24624658"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024404055","display_name":"Isaacs Diana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Isaacs","raw_affiliation_strings":["Cleveland Clinic Endocrinology & Metabolism Institute, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Endocrinology & Metabolism Institute, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5159226441"],"corresponding_institution_ids":["https://openalex.org/I24624658"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5876616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"2","first_page":"10","last_page":"19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9470000267028809},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.9789999723434448},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6169999837875366},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9589999914169312},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8920000195503235},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9229999780654907},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.949999988079071},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9539999961853027},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/treatment-disparities","display_name":"treatment disparities","score":0.47999998927116394},{"id":"https://openalex.org/keywords/health-care-access","display_name":"health care access","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6484000086784363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5133000016212463},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48890000581741333},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4235999882221222},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3804999887943268},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.3801000118255615},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3456999957561493},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30090001225471497},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3001999855041504},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29789999127388},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2815999984741211},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.2806999981403351},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.26919999718666077},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.263700008392334},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2590999901294708}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.17925/ee.2026.22.2.3","doi":"https://doi.org/10.17925/ee.2026.22.2.3","is_oa":true,"landing_page_url":"https://doi.org/10.17925/ee.2026.22.2.3","pdf_url":"https://touchendocrinology.com/wp-content/uploads/sites/5/2026/08/4.-touchENDO_22.2_Young_10-19.pdf","source":{"id":"https://openalex.org/S2764519077","display_name":"touchREVIEWS in Endocrinology","issn_l":"1758-3772","issn":["1758-3772","1758-3780","2752-5457"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"touchREVIEWS in Endocrinology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13730168","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13730168/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13730168/pdf/touchendo-22-2-10.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"touchREV Endocrinol","raw_type":"Text"},{"id":"pmid:42979257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42979257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"TouchREVIEWS in endocrinology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.17925/ee.2026.22.2.3","doi":"https://doi.org/10.17925/ee.2026.22.2.3","is_oa":true,"landing_page_url":"https://doi.org/10.17925/ee.2026.22.2.3","pdf_url":"https://touchendocrinology.com/wp-content/uploads/sites/5/2026/08/4.-touchENDO_22.2_Young_10-19.pdf","source":{"id":"https://openalex.org/S2764519077","display_name":"touchREVIEWS in Endocrinology","issn_l":"1758-3772","issn":["1758-3772","1758-3780","2752-5457"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"touchREVIEWS in Endocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308849","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31"},{"id":"https://openalex.org/F4320314107","display_name":"Touro University California","ror":"https://ror.org/0556gk990"},{"id":"https://openalex.org/F4320314206","display_name":"Sutter Health","ror":"https://ror.org/0060avh92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223173276.pdf","grobid_xml":"https://content.openalex.org/works/W7223173276.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1582261481","https://openalex.org/W1970134098","https://openalex.org/W2048975186","https://openalex.org/W2106036385","https://openalex.org/W2114598208","https://openalex.org/W2123319002","https://openalex.org/W2125769789","https://openalex.org/W2147222003","https://openalex.org/W2282578582","https://openalex.org/W2425644022","https://openalex.org/W2516535870","https://openalex.org/W2519510391","https://openalex.org/W2744843428","https://openalex.org/W2754041380","https://openalex.org/W2787255324","https://openalex.org/W2894746763","https://openalex.org/W2948612418","https://openalex.org/W2988918412","https://openalex.org/W2996686012","https://openalex.org/W3096909987","https://openalex.org/W3127371223","https://openalex.org/W3177365549","https://openalex.org/W3195404919","https://openalex.org/W3214063850","https://openalex.org/W4206445899","https://openalex.org/W4292340974","https://openalex.org/W4294771462","https://openalex.org/W4307893953","https://openalex.org/W4308027650","https://openalex.org/W4311927977","https://openalex.org/W4361219083","https://openalex.org/W4382049661","https://openalex.org/W4382051781","https://openalex.org/W4383893957","https://openalex.org/W4385415147","https://openalex.org/W4385772472","https://openalex.org/W4387008365","https://openalex.org/W4388592674","https://openalex.org/W4389480516","https://openalex.org/W4389500305","https://openalex.org/W4392359058","https://openalex.org/W4393852482","https://openalex.org/W4398781461","https://openalex.org/W4400766615","https://openalex.org/W4403970918","https://openalex.org/W4404437149","https://openalex.org/W4408960945","https://openalex.org/W4413306264","https://openalex.org/W4416489198","https://openalex.org/W4417121380","https://openalex.org/W4417497606"],"related_works":["https://openalex.org/W7163507083","https://openalex.org/W7163228476","https://openalex.org/W6906422771","https://openalex.org/W3112695040","https://openalex.org/W4294287419","https://openalex.org/W4225594685","https://openalex.org/W4233739543","https://openalex.org/W2995391560","https://openalex.org/W7141264211","https://openalex.org/W2748787309"],"abstract_inverted_index":{"The":[0,68],"impact":[1],"of":[2,11,74,115,155,203,217,225,234],"type":[3],"2":[4],"diabetes":[5],"(T2D)":[6],"extends":[7],"beyond":[8],"mere":[9],"management":[10,154],"blood":[12],"glucose;":[13],"it":[14],"also":[15,180],"encompasses":[16],"related":[17],"cardiovascular,":[18],"renal":[19,140],"and":[20,66,83,107,122,139,152,162,167,177,187,210,214],"metabolic":[21,156,163],"issues.":[22],"This":[23,100],"interconnected":[24],"framework,":[25],"known":[26],"as":[27,57,143,145,149,192],"the":[28,90,113,123,153,201,223,231],"cardio-renal-metabolic":[29],"(CRM)":[30],"syndrome,":[31],"calls":[32],"for":[33,54,227],"a":[34,49],"shift":[35],"in":[36,185],"therapeutic":[37,219],"approach.":[38],"While":[39],"traditional":[40],"treatments":[41],"have":[42],"made":[43],"progress":[44],"focusing":[45,96],"on":[46,81,97,182],"glucose":[47,98],"management,":[48,85],"residual":[50],"risk":[51,82],"still":[52],"exists":[53],"conditions":[55],"such":[56,148,191],"atherosclerotic":[58],"cardiovascular":[59,138],"disease,":[60,63],"chronic":[61],"kidney":[62],"heart":[64],"failure":[65],"obesity.":[67],"2025":[69],"American":[70],"Diabetes":[71],"Association":[72],"Standards":[73],"Care":[75],"now":[76],"emphasize":[77],"treatment":[78],"algorithms":[79],"based":[80],"complication":[84],"prioritizing":[86],"comorbidities":[87],"associated":[88],"with":[89,170],"CRM":[91,133,235],"syndrome":[92],"rather":[93],"than":[94],"solely":[95],"management.":[99],"article":[101],"consolidates":[102],"current":[103],"evidence,":[104],"mechanistic":[105],"insights":[106],"clinical":[108],"trial":[109],"findings":[110],"that":[111],"support":[112],"use":[114,194],"glucagon-like":[116],"peptide-1":[117],"receptor":[118,129],"agonists":[119,209],"(GLP-1":[120],"RAs)":[121],"dual":[124],"GLP-1/glucose-dependent":[125],"insulinotropic":[126],"polypeptide":[127],"(GIP)":[128],"agonist":[130],"to":[131,175],"reduce":[132],"risk.":[134],"We":[135],"examine":[136],"key":[137],"outcomes":[141],"trials,":[142,147],"well":[144],"metabolic-related":[146],"weight":[150],"loss":[151],"dysfunction-associated":[157,164],"steatotic":[158],"liver":[159],"disease":[160],"(MASLD)":[161],"steatohepatitis":[165],"(MASH),":[166],"their":[168],"alignment":[169],"guideline-directed":[171],"care.":[172],"In":[173],"addition":[174],"efficacy":[176],"safety,":[178],"we":[179,199],"focus":[181],"addressing":[183,230],"disparities":[184],"access":[186],"overcoming":[188],"implementation":[189],"challenges,":[190],"low":[193],"among":[195],"specific":[196],"subpopulations.":[197],"Lastly,":[198],"explore":[200],"future":[202],"incretin-based":[204],"therapies,":[205],"including":[206],"new":[207],"triple":[208],"ongoing":[211],"research.":[212],"Prompt":[213],"equitable":[215],"adoption":[216],"GLP-1-based":[218],"options":[220],"could":[221],"improve":[222],"standard":[224],"care":[226],"T2D":[228],"by":[229],"entire":[232],"range":[233],"syndrome.":[236]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}